Who owns the IP
The organizations most actively patenting around this compound, ranked by referenced patent volume.
| # | Assignee | Patents |
|---|---|---|
| 1 | Genentech Inc | 10 |
| 2 | Nuevolution AS | 7 |
| 3 | Syngenta Mogen BV | 6 |
| 4 | Deutsches Krebsforschungszentrum DKFZ | 5 |
| 5 | Novartis AG | 5 |
| 6 | Yissum Research Development Co of Hebrew University of Jerusalem | 5 |
| 7 | Hadasit Medical Research Services and Development Co | 4 |
| 8 | Lonza AG | 4 |
| 9 | Whitehead Institute for Biomedical Research | 4 |
| 10 | Asahi Kasei Corp | 3 |
Explore the full landscape
This preview shows the leading assignees. Cypris reveals the full ownership landscape - every filing entity, filing trends, and portfolio momentum.
Visit CyprisWhere innovation is concentrated
Patent classifications ranked by volume reveal the technical domains with the most active filing.
| # | Code | Area | Patents |
|---|---|---|---|
| 1 | C12N | Microorganisms, enzymes | 79 |
| 2 | A61K | Medicinal preparations | 43 |
| 3 | A61P | Therapeutic activity (drug indications) | 42 |
| 4 | C12Y | Enzyme nomenclature (EC numbers) | 36 |
| 5 | C12P | Fermentation, enzyme processes | 26 |
| 6 | C12Q | Measuring/testing involving enzymes | 26 |
| 7 | C07K | Peptides | 25 |
| 8 | G01N | Investigating / analysing materials | 21 |
| 9 | Y02E | Climate change mitigation: energy | 12 |
| 10 | C07D | Heterocyclic compounds | 11 |
AI mapped opportunity space
This preview shows where patent activity concentrates. Cypris maps the full classification landscape to surface technical whitespace and IP headroom.
See Cypris in actionWhere research is gaining momentum
Research themes ranked by publication activity show where scientific interest is accelerating around this compound.
| # | Research topic | Papers |
|---|---|---|
| 1 | Hormonal Regulation and Hypertension | 3 |
| 2 | Gene Regulatory Network Analysis | 1 |
Who's driving the science
The most-published authors working with this compound, alongside their primary affiliations.
| # | Author | Affiliation | Papers |
|---|---|---|---|
| 1 | Paul M. Stewart | University of Birmingham | 17 |
| 2 | Elizabeth A. Walker | University of Birmingham | 15 |
| 3 | Gareth G. Lavery | University of Birmingham | 13 |
| 4 | Gábor Bánhegyi | Semmelweis University | 12 |
| 5 | Angelo Benedetti | University of Siena | 11 |
| 6 | Alex Odermatt | University of Basel | 10 |
| 7 | Jeremy Tomlinson | University of Birmingham | 9 |
| 8 | Perrin C. White | The University of Texas Southwestern Medical Center | 8 |
| 9 | Iwona Bujalska | University of Birmingham | 6 |
| 10 | József Mandl | Semmelweis University | 6 |
Research leaders
This preview lists the top authors. Cypris surfaces the full researcher landscape, their affiliations, and how scientific influence is shifting.
See Cypris in actionThe literature that defines it
The most-cited papers anchoring the scientific record for this compound.
| Title | Year | Cited by | Topic |
|---|---|---|---|
| 11β-Hydroxysteroid Dehydrogenase Type 1: A Tissue-Specific Regulator of Glucocorticoid Response | 2004 | 973 | Hormonal Regulation and Hypertension |
| Mutations in the genes encoding 11β-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase interact to cause cortisone reductase deficiency | 2003 | 286 | Hormonal Regulation and Hypertension |
| Hexose‐6‐phosphate dehydrogenase determines the reaction direction of 11β‐hydroxysteroid dehydrogenase type 1 as an oxoreductase | 2004 | 208 | Ion Transport and Channel Regulation |
| Hexose-6-phosphate Dehydrogenase Knock-out Mice Lack 11β-Hydroxysteroid Dehydrogenase Type 1-mediated Glucocorticoid Generation | 2005 | 207 | Hormonal Regulation and Hypertension |
| Cooperativity between 11β-Hydroxysteroid Dehydrogenase Type 1 and Hexose-6-phosphate Dehydrogenase in the Lumen of the Endoplasmic Reticulum | 2004 | 168 | Hormonal Regulation and Hypertension |
Frequently asked questions
Common questions about this compound's patent and research landscape, answered from the underlying data.
What is the molecular composition of (3,4,5,6-tetrahydroxy-2-oxohexyl) dihydrogen phosphate?
Which organizations hold the most patents related to this compound?
What research topics are most associated with publications on this compound?
How has patent activity for this compound evolved in recent years?
Which research institutions have the most prolific authors publishing on this compound?